ID1 and neoplasm: In summary, we described a molecular mechanism whereby ID1 regulated Wnt/ β-catenin/c-MYC pathway, which in turn activated the PPP, thus encouraging tumor proliferation and oxaliplatin chemoresistance in HCC.